Clovis Oncology, Inc. (CLVS) Stock Price

62.18 ▲ +2.75 (+4.63%)
Open: 58.83 Vol: 1.46M Day's range: 58.83 - 62.96 Dec 08, 16:00 EST
IEX Real-Time Price
Loading chart ...
CLVS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY BUY NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 62.12▲ 62.29▼ 61.71▲ 59.53▲ 62.97▼
MA10 62.36▼ 61.60▲ 60.77▲ 60.05▲ 71.16▼
MA20 62.32▼ 60.71▲ 59.96▲ 62.05▲ 74.00▼
MA50 61.52▲ 59.63▲ 60.39▲ 71.63▼ 67.90▼
MA100 60.68▲ 60.37▲ 60.83▲ 73.87▼ 45.28▲
MA200 59.91▲ 61.22▲ 65.33▼ 69.70▼ 55.21▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.100▼ 0.183▲ 0.387▲ 0.437▲ -2.885▼
RSI 53.999▲ 69.732▲ 67.345▲ 44.446▼ 42.596▼
STOCH 8.369▼ 87.103▲ 92.215▲ 37.016     14.625▼
WILL %R -83.871▼ -18.886▲ -18.483▲ -38.672     -83.639▼
CCI -69.086     84.131     143.496▲ 41.407     -109.817▼
Latest Filters Detected On CLVS
PSAR&MOM $CLVS PSAR Switch Up + Momentum Set Alert
MA $CLVS Price Crossed Above MA(13) Set Alert
MA $CLVS Price Crossed Above MA(7) Set Alert
Clovis Oncology, Inc. News
Wednesday, December 06, 2017 07:10 AM
The Boulder-based company (Nasdaq: CLVS) seeks approval to use its ovarian cancer drug, rucaparib, as a maintenance treatment in women “with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are platinum sensitive” and ...
Wednesday, December 06, 2017 06:01 AM
Clovis Oncology (NASDAQ: CLVS) 2.1% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has accepted the companys supplemental New Drug Application (sNDA) for rucaparib and granted priority review status to the application with a ...
Wednesday, December 06, 2017 03:46 AM
This week, companies like Amgen AMGN, Revance Therapeutics, Inc. RVNC and AbbVie ABBV were in the news. While Amgen got FDA approval for the inclusion of cardiovascular outcomes data for its PCSK9 inhibitor, AbbVie and Revance provided data on their ...
CLVS historical stock data
date open high low close volume
08/12/17 58.83 62.96 58.83 62.18 1,459,989
07/12/17 59.07 59.98 58.74 59.43 779,695
06/12/17 58.24 59.705 57.505 58.98 969,601
05/12/17 59.19 59.79 57.47 57.73 741,896
04/12/17 62.35 62.35 59.27 59.33 828,171
01/12/17 62.02 62.43 58.76 61.395 967,060
30/11/17 60.245 63.21 60.00 62.93 1,304,213
29/11/17 58.53 60.65 58.53 60.145 1,074,010
28/11/17 59.61 59.61 57.72 58.88 1,385,460
27/11/17 61.015 61.05 58.69 59.45 1,106,634
Quote Details
Bid:62.15
Ask:62.22
52wk Low:35.38
52wk High:99.45
Vol:1.46M
Avg Vol(3m):18.7M
1Y Chng:+46.24%
1M Chng:-19.24%
Add to Watch List